Cardiovascular disease: risk assessment and reduction, including lipid modification

a low level, see the UK Chief Medical Officer's alcohol consumption guidelines. [2008] Smoking cessation 1.3.11 Advise and support all people who smoke to stop, in line with the recommendations on treating tobacco dependence in NICE's guideline on tobacco. [2008] Plant stanols and sterols 1.3.12 Do not advise any of the following to take plant stanols or sterols to prevent CVD: • people being treated for primary prevention • people being treated for secondary prevention • people with CKD • people with type 1 diabetes • people with type 2 diabetes. [2014] 1.4 Initial lipid measurement and referral for specialist review 1.4.1 Measure both total blood cholesterol and high-density lipoprotein (HDL) cholesterol to achieve the best estimate of CVD risk. [2008] 1.4.2 Use clinical findings, a full lipid profile and family history to judge the likelihood of a familial lipid disorder, rather than using strict lipid cut-off values alone. [2014, amended December 2023] 1.4.3 Exclude possible common secondary causes of dyslipidaemia (such as excess alcohol intake, uncontrolled diabetes, hypothyroidism, liver disease and nephrotic syndrome) before referring for specialist review. [2014] 1.4.4 Use the recommendations in NICE's guideline on familial hypercholesterolaemia to determine whether to suspect, and how to treat, familial
